The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this approach offers a more convenient way to administer https://leascmk808462.angelinsblog.com/39781153/glp-1-patches-a-novel-approach-to-diabetes-management